Detalhe da pesquisa
1.
Erratum: Correction of Affiliations in the Article "Validity of Outcome Prediction Scoring Systems in Korean Patients with Severe Adult Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation Therapy".
J Korean Med Sci
; 38(42): e380, 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904662
2.
PAK1 as a Potential Therapeutic Target in Male Smokers with EGFR-Mutant Non-Small Cell Lung Cancer.
Molecules
; 25(23)2020 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33261184
3.
Upregulation of P21-Activated Kinase 1 (PAK1)/CREB Axis in Squamous Non-Small Cell Lung Carcinoma.
Cell Physiol Biochem
; 50(1): 304-316, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30282071
4.
Current Status and Future of Lung Donation in Korea.
J Korean Med Sci
; 32(12): 1953-1958, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29115076
5.
The Utility of Preemptive Distal Perfusion Cannulation During Peripheral Venoarterial Extracorporeal Membrane Oxygenation Support.
J Interv Cardiol
; 29(4): 431-6, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27328624
6.
Impact of bloodstream infections on catheter colonization during extracorporeal membrane oxygenation.
J Artif Organs
; 19(2): 128-33, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26721824
7.
Validity of Outcome Prediction Scoring Systems in Korean Patients with Severe Adult Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation Therapy.
J Korean Med Sci
; 31(6): 932-8, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27247503
8.
Impact of Implementation of an Automated Liquid Culture System on Diagnosis of Tuberculous Pleurisy.
J Korean Med Sci
; 30(7): 871-5, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26130948
9.
Prevalence of chronic sputum and associated factors in Korean adults.
J Korean Med Sci
; 29(6): 825-30, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24932085
10.
Weight calibration in the joint modelling of medical cost and mortality.
Stat Methods Med Res
; 33(4): 728-742, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444359
11.
Immune checkpoint inhibitor score (IChIS) predicts survival benefit of immunotherapy in patients with non-small cell lung cancer.
Tuberc Respir Dis (Seoul)
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38749491
12.
The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multicenter Prospective Cohort Study.
Cancer Res Treat
; 56(2): 422-429, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871898
13.
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer.
Cancers (Basel)
; 16(3)2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339278
14.
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea.
Thorac Cancer
; 15(6): 448-457, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38171544
15.
Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study.
Thorac Cancer
; 14(27): 2777-2784, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37567781
16.
Initial Tumor Necrosis Factor-Alpha and Endothelial Activation Are Associated with Hemorrhagic Complications during Extracorporeal Membrane Oxygenation.
J Clin Med
; 12(13)2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445555
17.
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial.
Cells
; 12(9)2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174645
18.
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors.
Transl Lung Cancer Res
; 12(6): 1197-1209, 2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37425421
19.
Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer.
Cancer Res Treat
; 55(1): 112-122, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36049499
20.
Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study.
Cancer Res Treat
; 55(4): 1152-1170, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37218139